Print Print  
Award Information
Proposal Number: 0523004
Proposal Title: BioPhalanx, a hand portable discrete monolithic microarray biothreat detector
Topic Number: H-SB05.2-001
Phase: Phase II
Organization: Arcxis Biotechnologies
Address: 18858 Carlton Ave
Castro Valley, CA 94546-2908  
Abstract: The following proposal describes the planned effort of Arcxis Biotechnologies in the development of a rapid portable biosensor, we call BioPhalanxTM. During the Phase I SBIR project, we developed an alpha prototype for rapid point-of-care/point-of-incident instrument for the discrimination of biological agents. Our main overarching technical goal is to eliminate the need for PCR based detection, while retaining the necessary sensitivity, selectivity, rapid response, and robustness required in rugged field environments. Having completed the Phase I effort, we confidently believe based on the data generated that we have demonstrated the feasibility, in terms of sensitivity, selectivity, rapid response of the assay approach. Further the externally deployed prototype system demonstrated instantaneous detection of threat genes for B. Anthracis. The primary goals of this proposed effort are to 1) increase the sensitivity of the device, 2) produce the pre-production prototype that will be deployed to between at least five customers for the detection of no less than 20 CDC category A, B, C viruses and bacteria, and 3) develop a manufacturable system that will allow cost-effective production and sales of the BioPhalanx.
Award/Contract Number: NBCHC070088
Period of Performance: 07/02/2007 - 09/01/2009
Award/Contract Value: $999,201.46
Award/Obligated Amount: $749,249.09